Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

81. Johnson P N, Miller J L, Hagemann T M, Moffett B S. Assessment of inpatient admissions and top 25 medications for obese pediatric patients at two academic hospitals. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2016; 73 : 1243-9

82. Ibach B W, Miller J L, Woo S, Harrison D, Standifer K, Hagemann T M, Johnson P N. Characterization of tolerance in children receiving fentanyl continuous infusions. Journal of Pediatric Intensive Care. 2016

83. Capino A C, Dannaway D C, Miller J L. Metabolic Acidosis with Ophthalmic Dorzolamide in a Neonate. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2016; 21 : 256-9

84. Capino A C, Miller J L, Hughes K M, Miller M J, Johnson P N. Caregiver perception, self-efficacy, and knowledge of methadone tapers for children with iatrogenic opioid abstinence syndrome. Journal of Pharmacy Technology. 2016; 32 : 104-15

85. Johnson P N, Miller J L, Ranallo C. Dosing of Vasopressin in Critically Ill Children: Implications for Medication Safety. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2016; 17 : 277-8

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.

Read More